| Completed | Trial to Evaluate the Efficacy and Safety of Gemigliptin Compared With Placebo Added on Insulin Alone or on In Type 2 Diabetes Mellitus | Phase 3 | 2016-10-17 |
| Completed | To Compare and Evaluate the Efficacy and Safety of Ganilever PFS(Prefilled Syringe) and Orgalutran® Controlled Ovarian Stimulation | Phase 4 | 2016-10-01 |
| Completed | A Phase I Clinical Trial of a 13-valent Pneumococcal Conjugate Vaccine and 14-valent Pneumococcal Conjugate Va Pneumococcal Infections | Phase 1 | 2016-09-01 |
| Completed | Evaluation of the Ease of Use, Preference, and Safety of EutropinPen Inj. Short Stature, Idiopathic, Infant, Small for Gestational Age, Growth Hormone Deficiency | Phase 4 | 2016-08-11 |
| Completed | A Study Comparing LBAL to Humira® in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy Arthritis, Rheumatoid | Phase 3 | 2016-04-13 |
| Unknown | Study to Evaluate the Efficacy, Safety and PK of Intravenous Single Injection LC28-0126 Immediately Before PCI ST-segment Elevation Myocardial Infarction | Phase 2 | 2016-04-01 |
| Completed | A Study to Evaluate the Long-term Safety and Efficacy of LBEC0101 in Subjects With Active RA Despite Methotrex Rheumatoid Arthritis | Phase 3 | 2016-04-01 |
| Unknown | BE Study of the Combinations of Gemigliptin 50mg and Rosuvastatin 20mg in Comparison to Each Component Adminis Healthy | Phase 1 | 2016-03-01 |
| Unknown | BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 2000mg in Comparison to Ea Healthy | Phase 1 | 2015-08-01 |
| Completed | Extension Clinical Study to Evaluate the Long-term Efficacy and Safety of Repeat Treatment of YVOIRE Contour I Normal, Healthy Adults With Moderate, Severe, or Very Severe Volume Loss of Anteromedial Malar Region Who Have Completed the LG-HACL014 Study | N/A | 2015-05-01 |
| Completed | Observational Study to Evaluate Long-term Safety and Biodegradability of YVOIRE Volume s Correction of Nasolabial Folds | — | 2015-05-01 |
| Completed | Bioequivalence of a Single Subcutaneous Dose of BEPO and REPO in Healthy Male Subjects Healthy | Phase 1 | 2015-04-01 |
| Unknown | Post-authorization Safety Study of Euforvac-Hib Vaccine for Active Primary Immunization in Infants From 6 Week Diphtheria, Tetanus, Pertussis | — | 2015-03-01 |
| Unknown | A Study Comparing LBEC0101 to Enbrel® in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therap Arthritis, Rheumatoid | Phase 3 | 2015-02-01 |
| Completed | BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 500mg in Comparison to Eac Healthy | Phase 1 | 2014-12-01 |
| Completed | Observational Study to Evaluate Long-term Safety and Biodegradability of YVOIRE Classic s Correction of Nasolabial Folds | — | 2014-09-01 |
| Completed | Pharmacokinetics and Safety Study of LBAL in Healthy Subjects Healthy Subjects | Phase 1 | 2014-08-01 |
| Unknown | Observational Study to Evaluate the Safety and Efficacy for Levacalm Tab. Versus Valsartan/Amlodipine Combinat Lower Leg Edema, Orthostatic Hypertension | — | 2014-07-01 |
| Unknown | Phase III Trial to Evaluate the Efficacy and Safety of Gemigliptin 50mg qd Added to Ongoing Glimepiride as Fix Type 2 Diabetes Mellitus | Phase 3 | 2014-06-01 |
| Completed | Study to Assess the Efficacy and Safety of Eutropin in Prader-Willi Syndrome Prader-Willi Syndrome | Phase 3 | 2014-06-01 |
| Unknown | Clinical Study to Evaluate the Efficacy and Safety of YVOIRE® Contour Compared With Restylane SubQ™ Injected I Normal, Healthy Adults With Moderate, Severe, or Very Severe Volume Loss of Anteromedial Malar Region | N/A | 2014-05-01 |
| Completed | Gemigliptin-Rosuvastatin Fix-dose Combination Phase 3(BALANCE) Type 2 Diabetes, Dyslipidemia | Phase 3 | 2014-05-01 |
| Completed | A Clinical Trial to Evaluate the Safety and Efficacy of Retreatment With Intra-articular LBSA0103 Injections i Osteoarthritis of Knee | Phase 3 | 2014-04-01 |
| Completed | BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 1000mg in Comparison to Ea Healthy | Phase 1 | 2014-03-01 |
| Completed | Efficacy and Safety Study of Sr-hGH in Comparison With Daily hGH in ISS Patients Establishing Dose of Sr-hGH in ISS Patients | Phase 2 | 2014-02-01 |
| Completed | A Clinical Study to Evaluate the Efficacy and Safety of YVOIRE Classic Plus Versus YVOIRE Classic in Nasolabia Wrinkles | N/A | 2014-02-01 |
| Completed | Phase 2 Study to Evaluate the Efficacy, Safety and PK of Intravenous Single Injection LC28-0126 Immediately Be ST-segment Elevation Myocardial Infarction | Phase 2 | 2014-01-01 |
| Completed | Efficacy and Safety of Gemigliptin 50mg qd Added in Patients With Type 2 Diabetes Inadequately Controlled on G T2DM | Phase 3 | 2014-01-01 |
| Completed | A Clinical Study to Evaluate the Efficacy and Safety of YVOIRE Volume Plus Versus YVOIRE Volume in Nasolabial Wrinkles | N/A | 2013-11-01 |
| Completed | A Phase IIIb Study to Evaluate the Safety and Efficacy of Gemigliptin in Type 2 Diabetes Mellitus Patients Wit Type 2 DM Patients With Moderate or Severe Renal Impairment | Phase 3 | 2013-10-01 |
| Completed | Influence of Hepatic Impairment on Pharmacokinetic (PK) and Pharmacodynamic (PD) of Gemigliptin PK and PD Afte Hepatic Impairment | Phase 1 | 2013-09-01 |
| Completed | Multicenter, Randomized, Open Label, Parallel Study to Evaluate the Efficacy & Safety of IVF-M HP Inj. vs. Men Infertility, Female | Phase 4 | 2013-07-01 |
| Completed | An Observational Study to Evaluate Cardiovascular Outcomes of T2DM PatientsTreated With Gemigliptin Type 2 Diabetes Mellitus | — | 2013-06-28 |
| Completed | Pharmacokinetic Drug Interaction Study Between Gemigliptin and Irbesartan After Oral Administration in Healthy Healthy | Phase 1 | 2013-06-01 |
| Completed | Effects of Gemigliptin Versus Sitagliptin or Glimepiride With Metformin on Glucose Variability(MAGE, Glucose S Type 2 Diabetes Mellitus | Phase 4 | 2013-05-01 |
| Completed | Phase III Trial to Evaluate the Efficacy and Safety of Initial Combination Therapy With Gemigliptin 50mg q.d a Type 2 Diabetes Mellitus | Phase 3 | 2013-04-01 |
| Completed | Study for Investigate the Pharmacokinetic Drug Interactions Between Gemigliptin and Rosuvastatin Healthy | Phase 1 | 2013-04-01 |
| Completed | Pharmacokinetic Drug Interaction Study Between Gemigliptin and Glimepiride in Healthy Male Subjects Healthy | Phase 1 | 2013-02-01 |
| Completed | Food-Effect Bioavailability Study of FDC(Gemigliptin/Metformin HCl Sustained Release) 50/1000mg(25/500mg x 2ta Type 2 Diabetes | Phase 1 | 2013-01-01 |
| Completed | Study to Investigate the Safety and Pharmacokinetic Characteristics of LC28-0126 in Healthy Male Subjects Healthy | Phase 1 | 2012-12-01 |
| Completed | Safety and Pharmacokinetics Between Fixed-dose Combination VR 160/20 mg and Co-administration of Diovan® (Vals Hypertension, Hyperlipidemia | Phase 1 | 2012-12-01 |
| Completed | Study to Compare the Safety and Pharmacokinetic Characteristics of LBEC0101 25mg With Those of Enbrel® Healthy | Phase 1 | 2012-11-01 |
| Completed | BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 1000mg in Comparison to Ea Healthy | Phase 1 | 2012-10-01 |
| Terminated | To Assess the Anti-adhesive Effect and Safety of Protescal Laparoscopic Myomectomy | Phase 3 | 2012-09-01 |
| Completed | Phase III Clinical Study to Evaluate the Efficacy and Safety of the Combination of Lercanidipine/Valsartan in Hypertension | Phase 3 | 2012-05-01 |
| Completed | Efficacy and Safety of Valsartan 160mg and Rosuvastatin 20mg in Patients With Hypertension and Hyperlipidemia Hypertension,, Hyperlipidemia | Phase 3 | 2012-04-01 |
| Completed | Study to Assess the Effect on Recovery of GI Motility and Safety and to Determine the Optimal Dose of LD02GIFR Colon Resection, _large Interstinal Surgery | Phase 2 | 2012-03-01 |
| Completed | Study of LC23-1306 in Healthy Male Subjects Acute Coronary Syndrome | Phase 1 | 2012-03-01 |
| Unknown | Phase 4 Trial to Evaluate the Efficacy and Safety of Sancuso Patch in CINV (Chemotherapy-induced Nausea and Vo Chemotherapy-induced Acute or Delayed Nausea and Vomiting (CINV) | Phase 4 | 2012-02-01 |
| Completed | Efficacy and Safety of LBSA0103 Versus Hyruan Plus Injection in Patients With Knee Osteoarthritis Osteoarthritis of the Knee | Phase 3 | 2011-12-01 |
| Completed | Drug Interaction and Safety Between Valsartan and Rosuvastatin in Healthy Male Volunteers Hypertension, Hyperlipidemia | Phase 1 | 2011-09-01 |
| Completed | Phase 4 Trial to Evaluate the Efficacy and Safety of Sancuso Patch in Chemotherapy-induced Nausea and Vomiting Chemotherapy-induced Acute or Delayed Nausea and Vomiting (CINV) | Phase 4 | 2011-08-01 |
| Completed | Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of LC15-0444 and Metformin After Oral Administration in Healthy | Phase 1 | 2011-08-01 |
| Completed | Safety, Tolerability and Pharmacokinetic/Pharmacodynamic Characteristics of LC350189 Hyperuricemia, Gout | Phase 1 | 2011-06-01 |
| Completed | Study in Healthy Male Subjects Designed to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Healthy | Phase 1 | 2011-05-01 |
| Completed | Pharmacokinetics and Safety Study of Apetrol ES in Healthy Male Volunteers Healthy Male Volunteers | Phase 1 | 2011-03-01 |
| Completed | Pharmacokinetic Drug Interaction Study in Healthy Male Subjects Healthy Male Volunteers | Phase 1 | 2011-01-01 |
| Completed | Comparison of Efficacy and Safety Between Imidafenacin and Fesoterodine in Patients With Overactive Bladder Overactive Bladder | Phase 4 | 2010-12-01 |
| Completed | Bioequivalence of LB80380 Free Base and Maleate Salt Tablets Hepatitis B | Phase 1 | 2010-09-01 |
| Unknown | Long-term Safety and Efficacy Study of LB80380 in the Treatment-naive Patients of Chronic Hepatitis B Chronic Hepatitis B | Phase 2 | 2010-08-01 |
| Completed | Study to Compare the Safety and Pharmacokinetic Characteristics of LBEC0101 25 mg With Those of Enbrel® Healthy | Phase 1 | 2010-06-01 |
| Completed | Pharmacokinetics and Safety Study of Apetrol ES Healthy | Phase 1 | 2010-04-01 |
| Completed | Clinical Study to Evaluate the Correction of Facial Wrinkles and Folds and Safety of YVOIRE Volume Versus Perl Temporary Correction of Wrinkles | N/A | 2010-03-01 |
| Completed | Efficacy and Safety of Lercanidipine and Valsartan in Patients With Essential Hypertension Essential Hypertension | Phase 2 | 2009-12-01 |
| Completed | Phase III Trial to Evaluate the Efficacy and Safety of LC15-0444 Compared With Sitagliptin Added to Ongoing Me Type 2 Diabetes Mellitus | Phase 3 | 2009-12-01 |
| Completed | Phase 3 Trial to Evaluate the Efficacy and Safety of LC15-0444 in Patients With Type 2 Diabetes Type 2 Diabetes Mellitus | Phase 3 | 2009-12-01 |
| Completed | Safety and Efficacy of SR-hGH (Sustained-release Human Growth Hormone, Declage Inj.) Growth Hormone Deficiency | Phase 4 | 2009-12-01 |
| Completed | Safety and Efficacy Study of LB80380 in the Treatment-naive Patients of Chronic Hepatitis B Chronic Hepatitis B | Phase 2 | 2009-08-01 |
| Completed | A Phase III Study to Assess the Immunogenicity and Safety of Eutravac (DTap-HB Combined Vaccine) With DTaP and Healthy Infants | Phase 3 | 2009-08-01 |
| Completed | Pharmacokinetic Drug Interaction Between LC15-0444 and Pioglitazone After Oral Administration in Healthy Male Healthy | Phase 1 | 2009-02-01 |
| Completed | Clinical Study to Evaluate the Correction of Wrinkles and Folds and Safety of YVOIRE Classic Versus Restylane Temporary Correction of Wrinkles | N/A | 2009-01-01 |
| Completed | Immunogenicity and Safety Study of 4th LBVH0101 After the Primary Vaccination in LG-VHCL002 Study Infectious Disease by Haemophilus Influenzae Type b | Phase 3 | 2008-07-01 |
| Completed | Immunogenicity and Safety Study of LBVH0101 in Healthy Infants at Two, Four and Six Months of Age Infectious Disease by Haemophilus Influenzae Type b | Phase 3 | 2007-07-01 |
| Completed | Treatment of Adults With Growth Hormone Deficiency Pituitary Disorders, Adult Growth Hormone Deficiency | Phase 3 | 2006-08-01 |
| Completed | Treatment of Adults With Growth Hormone Deficiency Pituitary Disorders, Adult Growth Hormone Deficiency | Phase 3 | 2006-04-01 |
| Completed | Phase I Trial for Pharmacokinetic Characteristics of Factive 200mg Intravenous Formulation (Gemifloxacin 200mg Infectious Diseases | Phase 1 | 2006-01-01 |
| Unknown | Treatment of Children With Insufficient Secretion of Growth Hormone Growth Hormone Deficiency (GHD) | Phase 3 | 2005-09-01 |
| Completed | Safety and Efficacy Study of LB80380 in the Patients With Lamivudine-Refractory Chronic Hepatitis B Chronic Hepatitis B | Phase 1 / Phase 2 | 2004-03-01 |